To recapitulate, the inhibition of TOMM20 in human chondrosarcoma CH2879 reduced the expression of drivers of cancer aggressiveness, cell viability, and OXPHOS, but increased ROS levels. Here, TOMM20 is linked to chondrosarcoma.